Showing results (591-600 of 2,122) with videos related to
Sort By:
Pageof 213
Journal of Ovarian Research|October 31, 2021
An overview of FSH-FSHR biology and explaining the existing conundrumsDeepa Bhartiya, Hiren PatelJournal of Ovarian Research|May 3, 2022
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinomaZibi Marchocki, Alicia Tone, Carl Virtanen, et al.Journal of Ovarian Research|May 3, 2022
The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysisLili Qiu, Guangping WengJournal of Ovarian Research|April 28, 2022
Unusual presentation of primary ovarian diffuse large B-cell lymphoma: a case reportBin Luo, Rong-Quan He, Zhi-Gang Peng, et al.Journal of Ovarian Research|April 28, 2022
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancerYuqing Shen, Hui Lin, Kelie Chen, et al.Journal of Ovarian Research|July 26, 2022
Neuregulin-1 signaling regulates cytokines and chemokines expression and secretion in granulosa cellSaswati Banerjee, Sameer Mishra, Wei Xu, et al.Journal of Ovarian Research|July 14, 2022
Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical featuresKuan-Ju Huang, Ying-Xuan Li, Chin-Jui Wu, et al.Journal of Ovarian Research|February 20, 2022
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer stagingZehua Zhu, Zhaojun Chen, Mingxing Wang, et al.Journal of Ovarian Research|February 4, 2022
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumorsXuefen Liu, Tianping Wang, Guofu Zhang, et al.Journal of Ovarian Research|February 4, 2022
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancerXiaoli Cao, Juan Yao, Meiqun Jia, et al.Pageof 213